Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.631
+0.001 (0.19%)
At close: Mar 9, 2026, 4:00 PM EDT
0.634
+0.003 (0.46%)
After-hours: Mar 9, 2026, 8:00 PM EDT
Kairos Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 13 | 20 | - | - | - | - |
| Enterprise Value | 8 | 16 | - | - | - | - |
| Last Close Price | 0.63 | 1.52 | - | - | - | - |
| PB Ratio | 1.71 | 4.09 | - | - | - | - |
| P/TBV Ratio | 1.74 | 4.29 | - | - | - | - |
| Debt / Equity Ratio | - | - | -0.31 | -0.50 | -0.34 | -0.15 |
| Net Debt / Equity Ratio | -0.73 | -0.27 | -0.26 | -0.13 | -0.28 | -0.10 |
| Net Debt / EBITDA Ratio | 1.02 | 0.58 | -0.35 | -0.36 | -0.17 | - |
| Quick Ratio | 13.87 | 1.28 | 0.04 | 0.27 | 0.04 | 0.04 |
| Current Ratio | 16.56 | 4.20 | 0.04 | 0.27 | 0.04 | 0.04 |
| Return on Equity (ROE) | -92.07% | -192.96% | - | - | - | - |
| Return on Assets (ROA) | -53.59% | -43.50% | -107.07% | -39.41% | -307.71% | - |
| Return on Capital Employed (ROCE) | -73.10% | -49.10% | 119.00% | 95.60% | 166.50% | 305.10% |
| Earnings Yield | -38.52% | -13.33% | - | - | - | - |
| Buyback Yield / Dilution | -55.64% | -9.38% | -1.42% | -11.86% | 3.12% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.